Washington: The United States recommends "temporarily stopping" Johnson & Johnson's one-dose Kovid-19 vaccine to investigate reports of blood clotting. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said in a joint statement on Tuesday that they are investigating a case of blood clotting in six women a few days after vaccination.
The statement said that a blood thinner 'heparin' (drug) commonly used in its (blood clots) treatment may prove dangerous if blood clots are found in the blood along with a decreased number of platelets. . The statement said that more than 68 lakh doses of this vaccine have been given in the US, most of which have not seen any side effects.
US federal distribution centers, including mass vaccination centers, will temporarily stop Johnson & Johnson's vaccine doses, and provinces and other vaccinated parties are also expected to comply. However, two other vaccines Moderena and Pfizer will not apply this temporary moratorium. The CDC Advisory Committee on Immunization will meet on Wednesday to discuss matters. Additionally, the FDA has also begun investigations into blood clotting and platelet counts.
CDC's Principal Deputy Director Dr. Annie Suchat and the FDA's Center for Biologics Evaluation and Research Director Dr. Peter Marks said in a joint statement, "Until the process is complete, we are recommending a temporary ban on the use of this vaccine." . ' They have suggested that people who are experiencing headaches, abdominal pain, leg pain, or rapid breathing within three weeks after receiving the Johnson & Johnson vaccine should contact their healthcare provider . The vaccine was approved for emergency use by the FDA in late February.
It is noteworthy that concerns about blood clotting have so far only focused on the AstraZeneca vaccine, which has not yet been allowed to be used in the US. However, last week European regulators said that they had detected a possible association between vaccine doses and a very rare type of blood clot, which are produced in young people with low platelet counts. . It is noteworthy that Johnson & Johnson and AstraZeneca vaccines are made from the same technology. Shares of the company fell three percent following the announcement of a recommendation for a temporary moratorium on Johnson & Johnson vaccines.